(BATRK) Atlanta Braves Holdings - Overview
Stock: Baseball, Stadium, Retail, Hotel, Entertainment
EPS (Earnings per Share)
Revenue
| Risk 5d forecast | |
|---|---|
| Volatility | 18.5% |
| Relative Tail Risk | -2.06% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | -0.23 |
| Alpha | -12.58 |
| Character TTM | |
|---|---|
| Beta | 0.492 |
| Beta Downside | 0.609 |
| Drawdowns 3y | |
|---|---|
| Max DD | 19.63% |
| CAGR/Max DD | 0.27 |
Description: BATRK Atlanta Braves Holdings January 11, 2026
Atlanta Braves Holdings, Inc. (NASDAQ:BATRK) owns and operates the Atlanta Braves MLB franchise through its subsidiary Braves Holdings, LLC, and manages the Truist Park facility in Cobb County, Georgia. The company’s operations are split between the Baseball segment, which generates revenue from ticket sales, media rights, and sponsorships, and the Mixed-Use Development segment, centered on The Battery Atlanta-a 75-acre complex that includes retail, office, hotel, and entertainment venues.
Key metrics that analysts watch include: (1) average game attendance, which held at roughly 35,000 fans per home game in 2023, supporting strong gate-receipts; (2) The Battery Atlanta’s estimated annual retail and hospitality sales of about $200 million, contributing a growing non-baseball revenue stream; and (3) MLB’s league-wide media rights agreements, which have been expanding at a compound annual growth rate of ~5% and boost franchise broadcast income. The franchise’s valuation has risen alongside broader sports-team appreciation, driven by rising consumer discretionary spending and the premium placed on live-experience assets.
Given the blend of stable baseball cash flows and a high-growth mixed-use property, BATRK presents a hybrid exposure to both the sports entertainment and commercial real-estate sectors, but investors should monitor attendance trends, lease renewals at The Battery, and any changes in MLB’s revenue-sharing model.
For a deeper dive into BATRK’s valuation metrics and comparable peers, you may find ValueRay’s data platform useful.
Piotroski VR‑10 (Strict, 0-10) 2.0
| Net Income: -1.04m TTM > 0 and > 6% of Revenue |
| FCF/TA: -0.02 > 0.02 and ΔFCF/TA -0.86 > 1.0 |
| NWC/Revenue: -2.18% < 20% (prev -14.38%; Δ 12.20% < -1%) |
| CFO/TA 0.02 > 3% & CFO 27.7m > Net Income -1.04m |
| Net Debt (785.7m) to EBITDA (46.2m): 17.00 < 3 |
| Current Ratio: 0.87 > 1.5 & < 3 |
| Outstanding Shares: last quarter (63.8m) vs 12m ago 1.18% < -2% |
| Gross Margin: 36.64% > 18% (prev 0.21%; Δ 3643 % > 0.5%) |
| Asset Turnover: 92.72% > 50% (prev 43.56%; Δ 49.15% > 0%) |
| Interest Coverage Ratio: -0.54 > 6 (EBITDA TTM 46.2m / Interest Expense TTM 44.4m) |
Altman Z'' -1.88
| A: -0.02 (Total Current Assets 217.1m - Total Current Liabilities 249.7m) / Total Assets 1.67b |
| B: -0.34 (Retained Earnings -567.6m / Total Assets 1.67b) |
| C: -0.01 (EBIT TTM -23.9m / Avg Total Assets 1.61b) |
| D: -0.52 (Book Value of Equity -570.3m / Total Liabilities 1.10b) |
| Altman-Z'' Score: -1.88 = D |
Beneish M -3.02
| DSRI: 0.45 (Receivables 86.9m/88.1m, Revenue 1.50b/678.4m) |
| GMI: 0.57 (GM 36.64% / 20.73%) |
| AQI: 1.01 (AQ_t 0.35 / AQ_t-1 0.34) |
| SGI: 2.21 (Revenue 1.50b / 678.4m) |
| TATA: -0.02 (NI -1.04m - CFO 27.7m) / TA 1.67b) |
| Beneish M-Score: -3.02 (Cap -4..+1) = AA |
What is the price of BATRK shares?
Over the past week, the price has changed by -2.00%, over one month by -0.76%, over three months by +0.67% and over the past year by -2.00%.
Is BATRK a buy, sell or hold?
- StrongBuy: 3
- Buy: 0
- Hold: 1
- Sell: 0
- StrongSell: 0
What are the forecasts/targets for the BATRK price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 58.4 | 49.2% |
| Analysts Target Price | 58.4 | 49.2% |
| ValueRay Target Price | 40.5 | 3.6% |
BATRK Fundamental Data Overview February 03, 2026
P/S = 3.5198
P/B = 4.4956
Revenue TTM = 1.50b USD
EBIT TTM = -23.9m USD
EBITDA TTM = 46.2m USD
Long Term Debt = 655.1m USD (from longTermDebt, last quarter)
Short Term Debt = 111.0m USD (from shortTermDebt, last quarter)
Debt = 868.0m USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 785.7m USD (from netDebt column, last quarter)
Enterprise Value = 3.33b USD (2.55b + Debt 868.0m - CCE 82.2m)
Interest Coverage Ratio = -0.54 (Ebit TTM -23.9m / Interest Expense TTM 44.4m)
EV/FCF = -117.6x (Enterprise Value 3.33b / FCF TTM -28.3m)
FCF Yield = -0.85% (FCF TTM -28.3m / Enterprise Value 3.33b)
FCF Margin = -1.89% (FCF TTM -28.3m / Revenue TTM 1.50b)
Net Margin = -0.07% (Net Income TTM -1.04m / Revenue TTM 1.50b)
Gross Margin = 36.64% ((Revenue TTM 1.50b - Cost of Revenue TTM 948.4m) / Revenue TTM)
Gross Margin QoQ = 41.84% (prev 24.56%)
Tobins Q-Ratio = 1.99 (Enterprise Value 3.33b / Total Assets 1.67b)
Interest Expense / Debt = 1.42% (Interest Expense 12.3m / Debt 868.0m)
Taxrate = 27.99% (11.7m / 41.8m)
NOPAT = -17.2m (EBIT -23.9m * (1 - 27.99%)) [loss with tax shield]
Current Ratio = 0.87 (Total Current Assets 217.1m / Total Current Liabilities 249.7m)
Debt / Equity = 1.55 (Debt 868.0m / totalStockholderEquity, last quarter 560.3m)
Debt / EBITDA = 17.00 (Net Debt 785.7m / EBITDA 46.2m)
Debt / FCF = -27.74 (negative FCF - burning cash) (Net Debt 785.7m / FCF TTM -28.3m)
Total Stockholder Equity = 523.4m (last 4 quarters mean from totalStockholderEquity)
RoA = -0.06% (Net Income -1.04m / Total Assets 1.67b)
RoE = -0.20% (Net Income TTM -1.04m / Total Stockholder Equity 523.4m)
RoCE = -2.03% (EBIT -23.9m / Capital Employed (Equity 523.4m + L.T.Debt 655.1m))
RoIC = -1.42% (negative operating profit) (NOPAT -17.2m / Invested Capital 1.22b)
WACC = 6.02% (E(2.55b)/V(3.41b) * Re(7.73%) + D(868.0m)/V(3.41b) * Rd(1.42%) * (1-Tc(0.28)))
Discount Rate = 7.73% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 7.95%
Shares Correlation 3-Years: 33.33 | Cagr: 1.53%
Fair Price DCF = unknown (Cash Flow -28.3m)
EPS Correlation: 35.76 | EPS CAGR: 6.71% | SUE: 0.0 | # QB: 0
Revenue Correlation: 31.24 | Revenue CAGR: 90.02% | SUE: 4.0 | # QB: 1
EPS next Quarter (2026-03-31): EPS=-0.69 | Chg30d=+0.109 | Revisions Net=+1 | Analysts=2
EPS next Year (2026-12-31): EPS=-0.16 | Chg30d=+0.255 | Revisions Net=+3 | Growth EPS=+29.6% | Growth Revenue=+5.7%